Evidence map›Paper›PMID 41367968›Full record

ArticleJAACAP open2025

The Effectiveness of Transcranial Magnetic Stimulation in Adolescents and Young Adults With Major Depressive Disorder.

Paul E Croarkin, Scott T Aaronson, Linda L Carpenter, Todd M Hutton, Kenneth Pages, Bing Chen, Harold A Sackeim

Registry-linked trialAbstract read
In one paragraph

Article in JAACAP open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06699940 (A Retrospective Registry Study to Evaluate Application of NeuroStar® Advanced Therapy for Depression and Comorbid Anxiety in Adolescents), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06699940 completednot on this map

A Retrospective Registry Study to Evaluate Application of NeuroStar® Advanced Therapy for Depression and Comorbid Anxiety in Adolescents

TypeobservationalSponsorNeuroneticsRan2023 to 2023Enrolled7,690ConditionsMDDArmsTranscranial Magnetic Stimulation
3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Paul E CroarkinMayo Clinic, Rochester, Minnesota.
Scott T AaronsonSheppard Pratt Health System and University of Maryland, Baltimore, Maryland.
Linda L CarpenterButler Hospital and the Warren Alpert Medical School of Brown University, Providence, Rhode Island.
Todd M HuttonSouthern California TMS Center, Los Angeles, California.
Kenneth PagesTMS of South Tampa, Tampa, Florida.
Bing ChenNAMSA, St. Louis Park, Minneapolis, Minnesota.
Harold A SackeimMedical University of South Carolina, Charleston, South Carolina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To assess the real-world effectiveness of transcranial magnetic stimulation (TMS) for depression in large adolescent and young adult samples. Method: Clinical outcome data from 364 sites were extracted for adolescent (n = 682; ages 12-19 years) and young adult (n = 601; ages 20-21 years) patients treated with TMS for major depressive disorder. Primary outcomes included response and remission rates assessed with the Patient Health Questionnaire-9 (PHQ-9). Secondary outcomes included rates of clinically meaningful benefit and worsening of depression based on a meaningful change threshold of ±6 points on the PHQ-9, dose-response relationships in effectiveness, and trajectories of symptomatic improvement over the course of TMS treatment. Results: PHQ-9 response and remission rates were equivalent in adolescent and young adult groups. Following the TMS course, approximately 70% of both groups reported meaningful improvement, whereas less than 1% reported meaningful worsening. There were marked dose-response effects, with longer courses of TMS associated with greater improvement ( Conclusion: This study examined the largest samples to date of adolescents and young adults treated with TMS for major depressive disorder. In both groups, TMS resulted in marked improvement in depressive symptom severity. The magnitude of benefit, trajectory of symptomatic improvement, and dependency on number of treatment sessions demonstrated therapeutic effects similar to that reported in adults. Study Registration Information: A Retrospective Study to Evaluate NeuroStar Advanced Therapy in Adolescents; https://clinicaltrials.gov/study/NCT06699940. Diversity & Inclusion Statement: We worked to ensure sex and gender balance in the recruitment of human participants. We actively worked to promote sex and gender balance in our author group. We actively worked to promote inclusion of historically underrepresented racial and/or ethnic groups in science in our author group. While citing references scientifically relevant for this work, we also actively worked to promote sex and gender balance in our reference list. While citing references scientifically relevant for this work, we also actively worked to promote inclusion of historically underrepresented racial and/or ethnic groups in science in our reference list.

Indexed as

adolescencedose-responsemajor depressive disorderpatient registrytranscranial magnetic stimulation (TMS)

Identifiers

PMID41367968
PMCPMC12684655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.